Literature DB >> 6894922

The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60 S ribosomal subunit.

R Reisbig, S Olsnes, K Eiklid.   

Abstract

The cytotoxic test system for Shigella shigae toxin was improved and used to study the stability of the toxin to various pH values, temperature, and chemicals. Inhibition of protein synthesis is the first demonstrable effect in cells treated with Shigella toxin. This inhibition appears to be at the level of peptide chain elongation. An inhibition effect on cell-free protein synthesis is exhibited by toxin pretreated first with trypsin and then with dithiothreitol and 8 M urea or 1% sodium dodecyl sulfate. Ribosomes treated with toxin or its A1 fragment had lost most of their ability to polymerize [14C]phenylalanine in a poly(U)-dependent cell-free system. Salt-washed ribosomes in simple buffered solutions were inactivated at a rate of at least 40 ribosomes/(min) (A1 fragment). Addition of antitoxin immediately stopped further inactivation, but it did not reactivate the inactivated ribosomes. 60 S ribosomal subunits from toxin-treated ribosomes had a marked reduction in ability to support polyphenylanine synthesis, whereas 40 S subunits from toxin-treated ribosomes retained their activity. Toxin-treated ribosomes retained their ability to incorporate [3H]puromycin into growing peptide chains, indicating that the peptide bond formation is not the function inhibited.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6894922

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Toxin production by Campylobacter spp.

Authors:  T M Wassenaar
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit.

Authors:  S B Calderwood; D W Acheson; M B Goldberg; S A Boyko; A Donohue-Rolfe
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

3.  Pathogenesis of Shigella diarrhea. XVI. Selective targetting of Shiga toxin to villus cells of rabbit jejunum explains the effect of the toxin on intestinal electrolyte transport.

Authors:  G Kandel; A Donohue-Rolfe; M Donowitz; G T Keusch
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

4.  The operator and early promoter region of the Shiga toxin type 2-encoding bacteriophage 933W and control of toxin expression.

Authors:  Jessica S Tyler; Melissa J Mills; David I Friedman
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

5.  Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin.

Authors:  B Boyd; S Richardson; J Gariepy
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

6.  Identification and characterization of small molecules that inhibit intracellular toxin transport.

Authors:  Jose B Saenz; Teresa A Doggett; David B Haslam
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

Review 7.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Purification and biological characterization of shiga toxin from Shigella dysenteriae 1.

Authors:  J E Brown; D E Griffin; S W Rothman; B P Doctor
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

9.  The MAP kinase-activated protein kinase 2 (MK2) contributes to the Shiga toxin-induced inflammatory response.

Authors:  Jose B Saenz; Jinmei Li; David B Haslam
Journal:  Cell Microbiol       Date:  2009-11-27       Impact factor: 3.715

10.  Enzyme-linked immunosorbent assay for shigella toxin.

Authors:  A Donohue-Rolfe; M A Kelley; M Bennish; G T Keusch
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.